Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning.
about
Absence of opiate rewarding effects in mice lacking dopamine D2 receptorsDrugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving ratsOpioid modulation of ventral pallidal inputs.GABA(A) receptors in the ventral tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems.Prefrontal/accumbal catecholamine system processes high motivational salience.Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine.Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1Opiate versus psychostimulant addiction: the differences do matterAmphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers.An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).Dissociation of food and opiate preference by a genetic mutation in zebrafish.Loss of cocaine locomotor response in Pitx3-deficient mice lacking a nigrostriatal pathwayIncreased rewarding properties of morphine in dopamine-transporter knockout mice.Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area.Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area.Unraveling dopamine D3 receptor function in response to psychostimulants using a genetic approach.Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens.
P2860
Q28588136-4384887F-48E6-4C46-A322-64D19B150407Q29619737-36D52CF0-4F62-4411-95EC-A4DB4B9D4630Q33692766-05727FE7-F404-4C64-BCF4-4DFBED8D8A46Q33939402-A3A1B1E8-2470-4DFC-8324-32418B3E2D8BQ34285610-D043FCA2-5397-4371-9F16-2FF1F990EAA7Q34714448-FBECB22F-B11F-4435-8BD6-8498EF4DEAD5Q35783781-01F5F0DA-4E77-4C3F-B60B-72BBB7EFBA4BQ37039781-A61C34AD-BB12-473C-A5FF-2F0F455D2F48Q38425892-A55AB655-CDB8-4B07-ABB4-165B832A926AQ38711758-C5F711B5-3132-4E2B-A86B-E22A093FA583Q40283638-FFC5883D-3E26-4710-92DC-EE55E81FED00Q42568290-D1DEF553-A858-46CF-A58C-E6D60C500073Q42734773-676AE6F0-0E37-4C22-8D6E-5380B0EC2456Q44295864-8ACCF44A-30CD-4590-A784-36911C27F6D2Q44733402-66620884-D4DA-4D07-A551-7770CC2DD314Q47823604-146A52F5-F019-4D68-819F-225A40B0C2FDQ52147495-D1145A64-016A-418D-B551-F8853724552E
P2860
Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Neuroleptics block the positiv ...... easured by place conditioning.
@en
type
label
Neuroleptics block the positiv ...... easured by place conditioning.
@en
prefLabel
Neuroleptics block the positiv ...... easured by place conditioning.
@en
P1476
Neuroleptics block the positiv ...... easured by place conditioning.
@en
P2093
D van der Kooy
W B Mackey
P304
P356
10.1016/0091-3057(85)90492-7
P407
P577
1985-01-01T00:00:00Z